Jan 06, 2019
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $22.00 to $440.00.
The split itself did not change the total investment value.
Purple Biotech Ltd. (TASE:PPBT) operates in the Pharmaceuticals: major industry.
Purple Biotech Ltd. company overviewPurple Biotech Ltd.'s most recent stock split was on January 6, 2019. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Purple Biotech Ltd. (TASE:PPBT) has split its stock 3 times: a 1-for-100 reverse split on June 24, 2012, a 1-for-13 reverse split on November 30, 2014, and a 1-for-20 reverse split on January 6, 2019.
Purple Biotech Ltd. has split its stock 3 times. This history records 3 reverse splits between June 24, 2012 and January 6, 2019.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Purple Biotech Ltd.'s 1-for-20 reverse split on January 6, 2019, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Purple Biotech Ltd. has not announced a new split in our records. Its most recent split was on January 6, 2019, 7 years ago. Companies announce splits in advance, and any new TASE:PPBT split will appear on this page.
Already premium?